Hamilton Lane Inc (HLNE)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Hamilton Lane Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 94.90 $ — 24% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AAQS
10/10 Quality stockThe AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 17.4%
- Exp. sales growth 3Y > 5% 17.7%
- EBIT growth 10Y > 5% 17.5%
- Exp. EBIT growth 3Y > 5% 26.9%
- Net debt < 4x EBIT 0.0x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 15.2%
- Return on equity > 15% 27.2%
- ROCE > 15% 16.6%
- Expected return > 10% 37.6%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
8 of 10 Growth gemTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 12.8% failed
- More than 10% revenue growth is expected for the coming year 18.6% passed
- Share count grows by less than 3% a year 0.5% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 66.3% passed
- Gross margin at 40% or higher and without meaningful erosion 69.9% passed
- Goodwill from acquisitions does not grow faster than revenue 0.0% passed
- Net debt below twice EBITDA 7 m net cash passed
- Operating cash flow covers the profits of the last three years 275 m passed
- Return on capital at 15% or higher, or up versus two years ago 16.6% passed
- Insiders hold at least 10% or are net buyers 7.2% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 33.7% above the current price.
- Consensus
- Hold
- Analyst Ratings
- 6
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 03/31/2027 | 6.26 | 5.30 – 6.61 | 904 | 6.2% | 7 |
| 03/31/2028 | 7.36 | 6.89 – 7.70 | 1,051 | 17.6% | 5 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 1.52 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.97 | -4.50 | 168 | 12.20 | 31.50 | 64 | 59 |
| 2025: Q1 | 1.23 | 26.60 | 198 | 17.70 | 25.50 | 39 | 36 |
| 2025: Q2 | 0.99 | -9.60 | 176 | -10.60 | 30.50 | 129 | 128 |
| 2025: Q3 | 1.30 | 28.20 | 191 | 27.30 | 37.10 | 121 | 120 |
| 2025: Q4 | 1.07 | 10.10 | 199 | 18.00 | 29.40 | 74 | 72 |
| 2026: Q1 | 1.22 | -1.30 | 194 | -2.20 | 34.20 | 103 | 101 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | 180 | 76 | 1 | 0.03 | 82 | 87 | 241 |
| 2018 | 244 | 123 | 17 | 0.91 | 97 | 136 | 294 |
| 2019 | 252 | 104 | 34 | 1.38 | 112 | 170 | 361 |
| 2020 | 274 | 116 | 61 | 2.14 | 116 | 237 | 474 |
| 2021 | 342 | 156 | 98 | 2.94 | 188 | 238 | 1,137 |
| 2022 | 368 | 170 | 146 | 2.72 | 170 | 347 | 1,295 |
| 2023 | 529 | 240 | 109 | 2.03 | 227 | 415 | 1,141 |
| 2024 | 554 | 246 | 141 | 2.61 | 121 | 525 | 1,271 |
| 2025 | 713 | 317 | 217 | 4.56 | 301 | 717 | 1,690 |
| 2026 | 759 | 325 | 249 | 4.57 | 460 | 915 | 2,305 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Hamilton Lane Incorporated ist ein Private-Equity- und Venture-Capital-Unternehmen, spezialisiert auf Early-Venture-, Emerging-Growth-, Turnaround-, Middle-Market-, Mature-, Mid-Venture-, Bridge-, Buyout-, Distressed-/Vulture-, Loan- und Mezzanine-Investitionen in Wachstumskapitalunternehmen. Das Unternehmen verwaltet alternative Investmentstrateg…
| Employees | 785 |
|---|---|
| Headquarters | Philadelphia, PA |
| Address | 110 Washington Street, 19428 Philadelphia, United States |
| Phone | 610 934 2222 |
| Website | hamiltonlane.com |
| IPO Date | 1. Mar 2017 |
| ISIN | US4074971064 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Erik R. Hirsch | Co-CEO & Member of the Board | 1973 |
| Juan M. Delgado-Moreira C.F.A., Ph.D. | Co-CEO & Director | 1971 |
| Andrea F. Kramer | Chief Operating Officer | – |
| Mario Lucio Giannini | Executive Co-Chairman | 1954 |
| Hartley Raymond Rogers | Executive Co-Chairman | 1961 |
| Robert D. Shin | Chief Compliance Officer & Chief Risk Officer | – |
| Lucy MacNichol | Principal & Head of Corporate Communications | – |
| Sungji An | Managing Director, Head of Client Solutions APAC & Head of Korea | – |
| Kristin Brandt | Chief Human Resources Officer | – |
| Paul R. Yett | Managing Director | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.